Insider Transactions in Q2 2023 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.56%
|
$1,450,000
$58.0 P/Share
|
|
Jun 12
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-1.82%
|
$383,500
$59.63 P/Share
|
|
Jun 12
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.49%
|
$0
$0.46 P/Share
|
|
May 27
2023
|
Kirk G. Nielsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,982
+4.63%
|
-
|
|
May 27
2023
|
Jonathan D Root Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,982
+0.55%
|
-
|
|
May 27
2023
|
Donald B Milder Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,982
+1.16%
|
-
|
|
May 18
2023
|
Kirk G. Nielsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+3.96%
|
-
|
|
May 18
2023
|
Cynthia L Lucchese Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+6.57%
|
-
|
|
May 18
2023
|
Robert Keith Warner Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+23.11%
|
-
|
|
May 18
2023
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+11.64%
|
-
|
|
May 18
2023
|
Dana G Mead Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+25.57%
|
-
|
|
May 18
2023
|
Jonathan D Root Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+0.45%
|
-
|
|
May 18
2023
|
William Hoffman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+0.21%
|
-
|
|
May 18
2023
|
Rebecca Chambers Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+26.23%
|
-
|
|
May 18
2023
|
Donald B Milder Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+0.95%
|
-
|
|
May 17
2023
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,751
-1.1%
|
$879,819
$69.19 P/Share
|
|
May 17
2023
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
18,760
-1.18%
|
$1,294,440
$69.19 P/Share
|
|
May 17
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
41,891
-1.21%
|
$2,890,479
$69.19 P/Share
|
|
May 16
2023
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,176
-1.02%
|
$852,320
$70.87 P/Share
|
|
May 16
2023
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
17,916
-1.09%
|
$1,254,120
$70.87 P/Share
|
|
May 16
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,006
-1.11%
|
$2,800,420
$70.87 P/Share
|
|
May 15
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.34%
|
$1,750,000
$70.52 P/Share
|
|
May 12
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,750
-1.76%
|
$892,500
$70.3 P/Share
|
|
May 12
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.38%
|
$0
$0.46 P/Share
|
|
Apr 17
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.5%
|
$1,600,000
$64.72 P/Share
|
|
Apr 12
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,750
-0.85%
|
$816,000
$64.76 P/Share
|
|
Apr 12
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.27%
|
$0
$0.46 P/Share
|
|
Apr 01
2023
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,018
-0.08%
|
$123,098
$61.74 P/Share
|
|
Apr 01
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,572
-0.28%
|
$95,892
$61.74 P/Share
|
|
Apr 01
2023
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,999
-0.12%
|
$121,939
$61.74 P/Share
|
|
Apr 01
2023
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,125
-0.09%
|
$68,625
$61.74 P/Share
|